Expression of CD8+ CD28+ and CD8+ CD28- in the Peripheral Blood of Pancreatic Cancer Patients

Shunrong JI,Wantong YAO,Bo ZHANG,Yongfeng XU,Wenyan XU,Jin XU,Quanxing NI,Xianjun YU

2012-01-01

Abstract:Objective To explore the expression of CD28 and CD103 on CD8+T lymphocytes in the peripheral blood of pancreatic cancer patients and its clinical significance.Methods Flow cytometry was used to determine the expression of CD8 and CD28 on T lymphocytes in the peripheral blood of 52 patients with pancreatic cancer and 40 healthy volunteers.The expression of CD103 in the peripheral blood,cancer tissue and adjacent tissue of cancer was also assessed in 10 patients with pancreatic cancer.Results The level of CD8+CD28+ expression in the pancreatic cancer patients was significantly lower than that in healthy volunteers([9.88±4.32]% vs.[14.12±4.95]%,P0.01).There was no significant difference in the level of CD8+CD28-between the pancreatic cancer patients and healthy volunteers([13.13±5.52]% vs.[11.41±4.01]%,P0.05).The levels of CD8+CD28+ and CD8+CD28-expression on peripheral blood lymphocytes in the patients with lymph node metastasis were(10.92±4.54)% and(13.62±4.52)%.And the levels in the patients without lymph node metastasis were(10.54±3.83)% and(14.15±3.27)%.There were no significant differences in CD8+CD28+ and CD8+CD28-expression between the two groups(P0.05).The level of CD8+CD28+ in stage Ⅲ cancer patients([6.45±1.22]%) was significantly lower than that in stageⅠ([13.01±2.31]%),stageⅡ([10.79±1.64]%) and stage Ⅳ([10.5±1.45]%,P0.05 or 0.01).The expression of CD103 on tumor-infiltration lymphocytes(26%) was significantly higher than that on peripheral blood lymphocytes(2%) and lymphocytes of cancer-adjacent tissues(8%,P0.01).Conclusion The decrease and hypofunction of CD8+CD28+ cell and insufficiency of E-cadherin/αEβ7 interactions may be related to the impaired immunity of pancreatic cancer patients.